Loading company…
NCC-Bio provides cancer research services and develops targeted cancer therapies.
Founded in 2020 and based in Goyang-si, South Korea, NCC-Bio provides non-clinical cancer efficacy testing and develops targeted therapies, including programs for pancreatic cancer. Its customers include pharmaceutical companies, research institutions and clinical laboratories. In March 2026, it secured KRW 5 billion in funding from A-Stone Ventures and Kingo Investment Partners to support clinical trials.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in